Hideyuki Kuroki

1.1k total citations
36 papers, 904 citations indexed

About

Hideyuki Kuroki is a scholar working on Surgery, Epidemiology and Hepatology. According to data from OpenAlex, Hideyuki Kuroki has authored 36 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 15 papers in Epidemiology and 13 papers in Hepatology. Recurrent topics in Hideyuki Kuroki's work include Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). Hideyuki Kuroki is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). Hideyuki Kuroki collaborates with scholars based in Japan, United States and Singapore. Hideyuki Kuroki's co-authors include Toru Beppu, Hiromitsu Hayashi, Akira Chikamoto, Hirohisa Okabe, Shigeki Nakagawa, Kosuke Mima, Hideo Baba, Masayuki Watanabe, Daisuke Hashimoto and Hidetoshi Nitta and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Hideyuki Kuroki

35 papers receiving 895 citations

Peers

Countries citing papers authored by Hideyuki Kuroki

Since Specialization

Citations

This map shows the geographic impact of Hideyuki Kuroki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyuki Kuroki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyuki Kuroki more than expected).

Fields of papers citing papers by Hideyuki Kuroki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideyuki Kuroki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyuki Kuroki. The network helps show where Hideyuki Kuroki may publish in the future.

Co-authorship network of co-authors of Hideyuki Kuroki

This figure shows the co-authorship network connecting the top 25 collaborators of Hideyuki Kuroki. A scholar is included among the top collaborators of Hideyuki Kuroki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideyuki Kuroki. Hideyuki Kuroki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Advanced Cholangiocarcinoma With High Tumor Mutation Burden Achieving Complete Response to Immune Check Point Inhibitor 2024 ·Anticancer Research ·Hirohisa Okabe, (unknown), Hidetoshi Nitta, (unknown), (unknown), Daisuke Kuroda, Hideyuki Kuroki, Masahiko Hirota, Taizo Hibi, Hideo Baba, Hiroki Sugita	2
2	Combined Neutrophil-to-Lymphocyte Ratio Score Is Associated With Chemotherapeutic Response and Predicts Prognosis in Patients With Advanced Pancreatic Cancer 2024 ·Anticancer Research ·(unknown), (unknown), (unknown), (unknown), Daisuke Ogawa, Daisuke Kuroda, Hideyuki Kuroki, Masahiko Hirota, Taizo Hibi, Hideo Baba, Hiroki Sugita	2
3	Thrombospondin-1 overexpression stimulates loss of Smad4 and accelerates malignant behavior via TGF-β signal activation in pancreatic ductal adenocarcinoma 2022 ·Translational Oncology ·(unknown), Hiromitsu Hayashi, Norio Uemura, Yoko Ogata, Zhao Liu, Hiroki Sato, (unknown), Hideyuki Kuroki, Fumimasa Kitamura, Takayoshi Kaida, Takaaki Higashi, Shigeki Nakagawa, Kosuke Mima, Katsunori Imai, Yo‐ichi Yamashita, Hideo Baba	12
4	Enhancer of zeste homolog 2 (EZH2) regulates tumor angiogenesis and predicts recurrence and prognosis of intrahepatic cholangiocarcinoma 2018 ·HPB ·Shigeki Nakagawa, Hirohisa Okabe, (unknown), Ryuma Tokunaga, Naoki Umezaki, Takaaki Higashi, (unknown), Kota Arima, Yuki Kitano, Hideyuki Kuroki, Kosuke Mima, Hidetoshi Nitta, Katsunori Imai, Daisuke Hashimoto, Yo‐ichi Yamashita, Akira Chikamoto, Hideo Baba	17
5	An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression 2015 ·Cancer Research ·Hiromitsu Hayashi, Takaaki Higashi, Naomi Yokoyama, Takayoshi Kaida, Keita Sakamoto, (unknown), Takatsugu Ishimoto, Hideyuki Kuroki, Hidetoshi Nitta, Daisuke Hashimoto, Akira Chikamoto, Eiji Oki, Toru Beppu, Hideo Baba	121
6	The Neutrophil-to-Lymphocyte Ratio Predicts Malignant Potential in Intraductal Papillary Mucinous Neoplasms 2015 ·Journal of Gastrointestinal Surgery ·Kota Arima, Hirohisa Okabe, Daisuke Hashimoto, Akira Chikamoto, Hideyuki Kuroki, Katsunobu Taki, Takayoshi Kaida, Takaaki Higashi, Hidetoshi Nitta, Yoshihiro Komohara, Toru Beppu, Motohiro Takeya, Hideo Baba	36
7	Sarcopenia, but not visceral fat amount, is a risk factor of postoperative complications after major hepatectomy 2015 ·International Journal of Clinical Oncology ·Takaaki Higashi, Hiromitsu Hayashi, Katsunobu Taki, Keita Sakamoto, Hideyuki Kuroki, Hidetoshi Nitta, Daisuke Hashimoto, Akira Chikamoto, Toru Beppu, Hideo Baba	43
8	Rank classification based on the combination of indocyanine green retention rate at 15 min and 99mTc-DTPA-galactosyl human serum albumin scintigraphy predicts the safety of hepatic resection 2014 ·Nuclear Medicine Communications ·Hirohisa Okabe, Toru Beppu, Hiromitsu Hayashi, Kosuke Mima, Shigeki Nakagawa, Hideyuki Kuroki, Katsunori Imai, Hidetoshi Nitta, Toshiro Masuda, Daisuke Hashimoto, Akira Chikamoto, Masayuki Watanabe, Takatoshi Ishiko, Morikatsu Yoshida, Yasuyuki Yamashita, Hideo Baba	15
9	EZH2 Is Associated with Malignant Behavior in Pancreatic IPMN via p27Kip1 Downregulation 2014 ·PLoS ONE ·Hideyuki Kuroki, Hiromitsu Hayashi, Hirohisa Okabe, Daisuke Hashimoto, Hiroshi Takamori, Osamu Nakahara, Shigeki Nakagawa, (unknown), Akira Chikamoto, Toru Beppu, Masahiko Hirota, Ken-ichi Iyama, Hideo Baba	13
10	Enhancer of Zeste Homolog 2 (EZH2) Promotes Progression of Cholangiocarcinoma Cells by Regulating Cell Cycle and Apoptosis 2013 ·Annals of Surgical Oncology ·Shigeki Nakagawa, Hirohisa Okabe, Yasuo Sakamoto, Hiromitsu Hayashi, Daisuke Hashimoto, Naomi Yokoyama, Keita Sakamoto, Hideyuki Kuroki, Kosuke Mima, Hidetoshi Nitta, Katsunori Imai, Akira Chikamoto, Masayuki Watanabe, Toru Beppu, Hideo Baba	52
11	The modified Glasgow Prognostic Score (mGPS) is a good predictor of indication for palliative bypass surgery in patients with unresectable pancreatic and biliary cancers 2013 ·International Journal of Clinical Oncology ·Yoshiaki Ikuta, Hiroshi Takamori, Yasuo Sakamoto, Daisuke Hashimoto, Akira Chikamoto, Hideyuki Kuroki, Kazuya Sakata, Keita Sakamoto, Hiromitsu Hayashi, Katsunori Imai, Hidetoshi Nitta, Masahiko Hirota, Keiichiro Kanemitsu, Toru Beppu, Hideo Baba	14
12	Reactive fibroinflammatory pseudotumor of the pancreas: report of three cases 2013 ·Clinical Journal of Gastroenterology ·Keiko Hirata, Daisuke Hashimoto, Masahiko Hirota, Kazuya Sakata, Hideyuki Kuroki, Takaaki Ito, Shinji Ishikawa, (unknown), Yasushi Yagi	1
13	Remnant liver volume-based predictors of postoperative liver dysfunction after hepatectomy: analysis of 625 consecutive patients from a single institution 2013 ·International Journal of Clinical Oncology ·Hirohisa Okabe, Toru Beppu, Akira Chikamoto, Hiromitsu Hayashi, Morikatsu Yoshida, Toshiro Masuda, Katsunori Imai, Kosuke Mima, Shigeki Nakagawa, Hideyuki Kuroki, Hidetoshi Nitta, Takatoshi Ishiko, Daisuke Hashimoto, Yasuyuki Yamashita, Hideo Baba	19
14	Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells 2013 ·Oncology Reports ·Shigeki Nakagawa, Yasuo Sakamoto, Hirohisa Okabe, Hiromitsu Hayashi, Daisuke Hashimoto, Naomi Yokoyama, Ryuma Tokunaga, Keita Sakamoto, Hideyuki Kuroki, Kosuke Mima, Toru Beppu, Hideo Baba	38
15	CD44s Regulates the TGF-β–Mediated Mesenchymal Phenotype and Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma 2012 ·Cancer Research ·Kosuke Mima, Hirohisa Okabe, Takatsugu Ishimoto, Hiromitsu Hayashi, Shigeki Nakagawa, Hideyuki Kuroki, Masayuki Watanabe, Toru Beppu, Mayumi Tamada, Osamu Nagano, Hideyuki Saya, Hideo Baba	181
16	The expression levels of CD44v6 are correlated with the invasiveness of hepatocellular carcinoma in vitro, but do not appear to be clinically significant 2012 ·Oncology Letters ·Kosuke Mima, Hirohisa Okabe, Takatsugu Ishimoto, Hiromitsu Hayashi, Shigeki Nakagawa, Hideyuki Kuroki, Keisuke Miyake, Hiroshi Takamori, Toru Beppu, Hideo Baba	7
17	Glasgow Prognostic Score as a useful prognostic factor after hepatectomy for hepatocellular carcinoma 2012 ·International Journal of Clinical Oncology ·Kei Horino, Toru Beppu, Hideyuki Kuroki, Kosuke Mima, Hirohisa Okabe, Osamu Nakahara, Yoshiaki Ikuta, Akira Chikamoto, Takatoshi Ishiko, Hiroshi Takamori, Hideo Baba	34
18	Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence 2012 ·International Journal of Clinical Oncology ·Kosuke Mima, Toru Beppu, Akira Chikamoto, Yuji Miyamoto, Shigeki Nakagawa, Hideyuki Kuroki, Hirohisa Okabe, Hiromitsu Hayashi, Yasuo Sakamoto, Masayuki Watanabe, Ken Kikuchi, Hideo Baba	29
19	Trichoblastic carcinoma arising from colostomy 2011 ·The American Journal of Surgery ·Daisuke Hashimoto, Hideyuki Kuroki, Yutaka Motomura, Shinji Ishikawa, (unknown), Naoko Udaka, (unknown), (unknown), Masahiko Hirota, Yasushi Yagi, Hideo Baba	4
20	Acute afferent loop necrosis after Roux-en-Y cholangiojejunostomy 2010 ·Clinical Journal of Gastroenterology ·Daisuke Hashimoto, (unknown), Hideyuki Kuroki, Yutaka Motomura, Shinji Ishikawa, (unknown), Naoko Udaka, (unknown), Masahiko Hirota, Yasushi Yagi, Hideo Baba	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact